Crossmark

Adjuvant chemotherapy with or without EGFR-TKIs for resected EGFR-mutated non-small cell lung cancer: a pooled analysis of four randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s12885-026-16514-0

Published Online: 2026-07-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Sui

Guo, Feilong

Zhu, Jiafu

Lin, Jiangbo https://orcid.org/0009-0003-6450-8989
License Information

Text and Data Mining valid from 2026-07-15

Accepted Manuscript valid from 2026-07-15
More Information

Article History

Received: 30 April 2026

Accepted: 6 July 2026

First Online: 15 July 2026

Declarations

Ethics approval and consent to participate: This article does not contain any studies with human participants or animals performed by any of the authors.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below